138 Results for "

FAAH

" in MedChemExpress (MCE) Product Catalog:
Products (138)

138 Results for "FAAH" in MCE Product Catalog:

  • Targets Recommended:
17
17 Publications Verification
Cat. No.: HY-14595
CAS No.: 491-80-5
Purity:  99.29%
Synonyms: 4-Methylgenistein; Olmelin
Biochanin A is a naturally occurring fatty acid amide hydrolase (FAAH) inhibitor, which inhibits FAAH with IC50s of 1.8, 1.4 and 2.4 μM for mouse, rat, and human FAAH, respectively.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B1227
CAS No.: 53716-49-7
Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-15249
CAS No.: 1101854-58-3
Purity:  99.46%
Target:  

MAGL

Research Areas:  

Neurological Disease

JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-14376
CAS No.: 1020315-31-4
Purity:  99.89%
Synonyms: PF-04457845
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

Redafamdastat (PF-04457845), a chemical probe, is a highly efficacious and selective FAAH inhibitor with IC50 values is 7.2±0.63 nM and 7.4±0.62 nM for hFAAH and rFAAH, respectively.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0182
CAS No.: 61422-45-5
Synonyms: HCFU
Carmofur (HCFU) is a rat recombinant acid ceramidase inhibitor with an IC50 of 29 nM. Carmofur is also a protease inhibitor of SARS-CoV-2 main protease (Mpro), fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA). Carmofur has anti-cancer, anti-inflammatory and anti-virus activities, and can be used for the study of COVID-19 and acute lung injury (ALI) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10864
CAS No.: 546141-08-6
Purity:  99.15%
Synonyms: KDS-4103
Target:  

FAAH Autophagy Mitophagy

Research Areas:  

Neurological Disease

URB-597 (KDS-4103) is an orally bioavailable and selective FAAH inhibitor. URB-597 inhibits FAAH activity with an IC50s of approximately 5 nM in rat brain membranes, 0.5 nM in intact rat neurons, 3 nM in human liver microsomes. Antidepressant-like effects. Analgesic activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15250
CAS No.: 1210004-12-8
Purity:  99.75%
Target:  

FAAH MAGL Autophagy

Research Areas:  

Neurological Disease

JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10865
CAS No.: 874902-19-9
Purity:  98.01%
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18977
CAS No.: 1380424-42-9
Target:  

MAGL

KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14380
CAS No.: 1196109-52-0
Purity:  99.95%
Target:  

FAAH Autophagy

Research Areas:  

Inflammation/Immunology Cancer

PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 μM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2365
CAS No.: 74058-71-2
Synonyms: N-Benzylpalmitamide; N-Benzylhexadecanamide; Macamide 1
Macamide B (N-Benzylhexadecanamide; Macamide 1) is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19740
CAS No.: 1233855-46-3
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18540
CAS No.: 1402612-55-8
Target:  

MAGL DAGL

KT109 is a potent and an isoform-selective inhibitor of diacylglycerol lipase-β (DAGLβ) with an IC50 of 42 nM. KT109 has ~60-fold selectivity for DAGLβ over DAGLα. KT109 shows inhibitory activity against PLA2G7 (IC50=1 µM). KT109 shows negligible activity against FAAH, MGLL, ABHD11, and cytosolic phospholipase A2 (cPLA2 or PLA2G4A). KT109 perturbs a lipid network involved in macrophage inflammatory responses and lowers 2-Arachidonoylglycerol (HY-W011051), Arachidonic acid (HY-109590) and eicosanoids in mouse peritoneal macrophages .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2512
CAS No.: 589-68-4
1-Monomyristin acts as an insecticide, enzyme inhibitor, antibacterial and antifungal agent, with an IC50 of 18 μM against rat FAAH and an IC50 of 32 μM against rat MAGL. 1-Monomyristin inhibits 2-oleoylglycerol hydrolysis via MAGL. 1-Monomyristin suppresses the growth of Staphylococcus aureus, Aggregatibacter actinomycetemcomitans and Candida albicans. 1-Monomyristin is lethal to brine shrimp . 1-Monomyristin exhibits marginal cytotoxicity against prostate cancer cells. 1-Monomyristin is applicable to research related to bacterial infections, fungal infections, renal cancer, prostate adenocarcinoma and pancreatic cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-79511
CAS No.: 184475-71-6
Synonyms: O-Desmorpholinopropyl Gefitinib
Target:  

FAAH Autophagy EGFR

Research Areas:  

Others

FAAH-IN-2 (O-Desmorpholinopropyl Gefitinib) is an inhibitor of FAAH. FAAH-IN-2 is a metabolite of Gefitinib (HY-50895) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3033
CAS No.: 883715-18-2
N-​Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119283
CAS No.: 359714-55-9
Purity:  99.58%
Synonyms: MAGL-IN-5
CAY10499 (MAGL-IN-5) is a non-selective lipase inhibitor with IC50 values of 144 nM and 14 nM for monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. Additionally, CAY10499 exhibits anti-inflammatory and antiviral activities .
loading...
    loading...
Cat. No.: HY-116477
CAS No.: 1357160-72-5
Purity:  99.85%
Target:  

FAAH

URB937 is an orally active and peripherally restricted FAAH inhibitor (IC50=26.8 nM) and increases anandamide levels. URB937 fails to affect FAAH activity in the brain (not penetrate the blood-brain barrier) .
loading...
    loading...
Cat. No.: HY-10862
CAS No.: 326866-17-5
Purity:  98.91%
Synonyms: Benzothiazole analog 3
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease Cancer

FAAH inhibitor 1 (compound 3) is a selective reversible FAAH inhibitor. FAAH inhibitor 1 has no off-target activity with respect to other serine hydrolases. FAAH inhibitor 1 is exclusively specific against FAAH in rat brain with an IC50 value of 18 nM and had no missing protein bands in all the other tissues. FAAH inhibitor 1 can be used for neurological disorders research .
loading...
    loading...
Cat. No.: HY-77491
CAS No.: 1010096-65-7
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects .
loading...
    loading...